Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy
- PMID: 10594538
- DOI: 10.1046/j.1365-2222.1999.00656.x
Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy
Abstract
Background: Patients who receive immunotherapy for systemic reaction to insect stings are told that once they reach maintenance dose they are almost 100% protected against future systemic reactions. However, we have observed that some patients continued to perceive themselves as highly debilitated by the allergy, and this perception had a significant impact on their quality of life.
Objective: To validate this clinical observation and to explore possible reasons for such an undesired psychological reaction.
Methods: The study group consisted of 97 patients who regularly attended an allergy outpatient clinic for venom immunotherapy, and who had been under medical surveillance for up to 8 years. They completed a questionnaire measuring debilitating beliefs, preoccupation with the systemic reaction event, emotional distress, perceived restriction by allergy, and perceived quality of life. We also recorded the duration of immunotherapy, physician-graded severity of the systemic reaction and the frequency at which immunotherapy was administered. The reference group consisted of patients who had not reached maintenance dose and were still at risk of recurrent systemic reactions.
Results: As many as one-third of the patients held self-imposed debilitating beliefs, were preoccupied with the systemic reaction event, perceived a moderate to severe impairment in their quality of life, and manifested symptoms of emotional distress. These psychological responses did not correlate with the immunotherapy dosage that had been reached. Patients who reached a full maintenance dose were doing no better psychologically than those in the reference group. Moreover, the length of time on immunotherapy did not result in attenuation of the psychological responses.
Conclusion: This study demonstrates for the first time, the long-lasting psychological impact of a threatening systemic reaction. It suggests a need for intervention aimed at dispelling patients' unfounded and persisting debilitating beliefs.
Comment in
-
The influence of beliefs on the quality of life of patients with allergic diseases.Clin Exp Allergy. 1999 Dec;29(12):1591-2. doi: 10.1046/j.1365-2222.1999.00735.x. Clin Exp Allergy. 1999. PMID: 10594533 No abstract available.
Similar articles
-
Debilitating beliefs and emotional distress in patients given immunotherapy for insect sting allergy: a prospective study.Allergy Asthma Proc. 2009 Sep-Oct;30(5):546-51. doi: 10.2500/aap.2009.30.3266. Allergy Asthma Proc. 2009. PMID: 19843407
-
Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.Int Arch Allergy Immunol. 2011;156(1):90-8. doi: 10.1159/000322258. Epub 2011 Mar 30. Int Arch Allergy Immunol. 2011. PMID: 21447964 Clinical Trial.
-
Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.J Allergy Clin Immunol. 2001 May;107(5):902-6. doi: 10.1067/mai.2001.114986. J Allergy Clin Immunol. 2001. PMID: 11344360
-
[Desensitization of allergy to hymenoptera venoms].Wien Med Wochenschr. 1999;149(14-15):421-8. Wien Med Wochenschr. 1999. PMID: 10584286 Review. German.
-
[Allergic reactions to insect bites].Ther Umsch. 1989 Sep;46(9):654-62. Ther Umsch. 1989. PMID: 2678576 Review. German.
Cited by
-
10Vida: A Mental and Physical Health Intervention for Chronically Ill Adolescents and Their Caregivers in the Hospital Setting: An Open Study.Int J Environ Res Public Health. 2022 Mar 8;19(6):3162. doi: 10.3390/ijerph19063162. Int J Environ Res Public Health. 2022. PMID: 35328851 Free PMC article.
-
Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy.World Allergy Organ J. 2021 Apr 21;14(5):100536. doi: 10.1016/j.waojou.2021.100536. eCollection 2021 May. World Allergy Organ J. 2021. PMID: 33995819 Free PMC article.
-
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy.Animals (Basel). 2023 Sep 23;13(19):3002. doi: 10.3390/ani13193002. Animals (Basel). 2023. PMID: 37835609 Free PMC article.
-
Long-term impact of hymenoptera venom immunotherapy on clinical course, immune parameters, and psychosocial aspects.Allergol Select. 2021 Jan 26;5:57-66. doi: 10.5414/ALX02175E. eCollection 2021. Allergol Select. 2021. PMID: 33521509 Free PMC article.
-
Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy.Arch Med Sci. 2012 Dec 20;8(6):1076-82. doi: 10.5114/aoms.2012.32419. Epub 2012 Dec 19. Arch Med Sci. 2012. PMID: 23319984 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials